InvestSMART

Andromeda Metals Limited (ASX:ADN)

ALERT: Price-sensitive ASX Announcement for ADN
Current share price for ADN : $0.008 0 (0%)+
Announcement
Release
22 Jun 2026 9:39AM
Price at Release
$0.008
Full Release
download
Summary
Andromeda Metals Limited announced the commissioning of their High Purity Alumina (HPA) pilot plant, marking a significant milestone in the commercialisation of HPA production. The pilot plant is expected to produce commercial samples of 4N HPA for customer qualification by the second half of 2026. The project is based on Andromeda's proprietary process using high-quality Great White kaolin feedstock. The 2025 Scoping Study has already indicated strong project economics and potential for low-cost production. Additional value may be derived from by-products, including amorphous silica and gallium, which adds strategic importance to the project. The commissioning signifies progress in Andromeda's broader HPA commercialisation strategy, aiming to penetrate global markets with a competitive cost structure.
Key Points
  • Commissioning of Andromeda’s HPA pilot plant is underway, with testwork to continue through Q3 2026.
  • Commercial 4N HPA samples are targeted for customer qualification in the second half of 2026.
  • The 2025 Scoping Study reported strong economics and low-cost production potential for the HPA project.
  • There is potential upside from by-products, including silica and gallium.
  • The proprietary process utilizes high-quality Great White kaolin feedstock from the Great White Project.
  • Pilot plant testwork aims to produce HPA using a continuous process, transitioning from batch processing.
  • The pilot plant will generate commercial samples and assess scalability for future feasibility studies.
  • By-products generated during testwork, such as amorphous silica, have potential commercial applications.
  • Gallium, considered a critical mineral, is present in the Great White kaolin feedstock and may represent an additional value pathway.
  • The commissioning of the pilot plant marks a significant step in advancing Andromeda's HPA commercialisation strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.